Medical University Graz
Graz, Styria, 8036, Austria
NCT Number: NCT06072092
This study aims to optimize the treatment of out-of-hospital cardiac arrest (OHCA) by focusing on neurological outcomes through Bispectral Index (BIS) monitoring. It will evaluate the feasibility of BIS monitoring in the prehospital phase, assess the need for sedation based on BIS values, and examine the timing of interventions in ICU (intensive care unit) settings to identify irreversible Hypoxic-Ischemic Brain Injury (HIBI).
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Graz, Styria, 8036, Austria
The research project is designed to contribute to the low survival discharge rates of OHCA patients in Europe, which is currently around 8%.
Objectives:
Phases:
Methodology:
The project will utilize prehospital and ICU settings for a multidisciplinary approach, integrating cardiological, neurological, and anesthesiological perspectives. A pilot phase of 5 patients will be conducted initially to fine-tune the protocol and address any technical issues with the equipment.
Timeline:
The study will span approximately 14 months, starting with patient recruitment, data collection, and analysis and ending with the publication of results.
This project aims to provide critical insights into the feasibility and effectiveness of BIS monitoring in improving neurological outcomes for OHCA patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No interventions will be administered, but in addition to the standard of care according to the Guidelines of the European Resuscitation Council 2021, a frontal EEG-monitoring (BIS), a CPRMeter and a FlowMeter will be installed. The study will be observational only; the readings of the BIS monitor will be blinded to the treating PRU team.
Time frame: From PRU arrival until hand-over to the hospital (prehospital phase), on average 60 minutes.
To evaluate if frontal EEG (BIS) measurements are feasible and valid under CPR and at ROSC in the prehospital setting. The proportion of patients meeting the signal quality criteria in more than 75% of the measurement period (Signal quality index >75, Electromyogram <30) will be presented with a two-sided 95% confidence interval to assess the primary aim.
Time frame: Prehospital phase, on average 60 minutes.
The prehospital BIS feasibility will be assessed with a short questionnaire about the application and its handling.
Time frame: Prehospital phase, on average 60 minutes.
To find the optimal mean BIS cut-off after ROSC throughout the prehospital phase associated with higher CPC scores at 1 month after the event.
Time frame: Prehospital phase, on average 30 minutes.
To assess the correlation of BIS and etCO2 values in OHCA patients receiving CPR under evaluation of CPR quality.
Time frame: Prehospital phase, on average 30 minutes.
Patients with higher mean BIS values (>25) will require earlier and more sedation than patients with values below.
Time frame: ICU stay, on average 4 days.
To assess all timings of interventions on ICU indicating irreversible HIBI.
Medical University of Graz
Other
Frontal EEG in Out-of-hospital Cardiac Arrest - a Prospective Observational Feasibility Study
Acronym: FEICA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05784480
Cardiopulmonary Arrest, Cardiovascular Diseases
Vienna, Austria
View Trial DetailsNCT04806958
Cardiovascular Diseases, Heart Arrest
Columbus, Ohio, United States
View Trial DetailsNCT06672159
Arrhythmias, Cardiac, Cardiac Arrest
Trondheim, Norway
View Trial DetailsNCT06473207
Cardiovascular Diseases, Heart Arrest
Toulon, Var, France
View Trial Details